Abstract
Middle East and Africa Drug Delivery Devices Market Outlook to 2017
Summary
GlobalData’s new report, “Middle East and Africa Drug Delivery Devices Market Outlook to 2017” provides key market data on the Middle East and Africa Drug Delivery Devices market - Israel, Saudi Arabia and South Africa. The report provides value (USD million) data for all the market categories - Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
• Countries covered include Israel, Saudi Arabia and South Africa.
• Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.
• Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.
• 2010 company shares and distribution shares data for each of the market categories and countries.
• Global corporate-level profiles of key companies operating within the Middle East and Africa Drug Delivery Devices market
• Key players covered include GlaxoSmithKline plc, AstraZeneca PLC, Boehringer Ingelheim GmbH, Cipla Medpro (Pty) Ltd., Hospira, Inc., B. Braun Melsungen AG and others.
Reasons to buy
• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Middle East and Africa Drug Delivery Devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
Companies Mentioned
GlaxoSmithKline plc
AstraZeneca International plc
Boehringer Ingelheim GmbH
Cipla Medpro (Pty) Ltd.
Hospira, Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
Medtronic, Inc.
Baxter International Inc.
Smiths Medical
Terumo Corporation
CareFusion Corporation
3M Health Care
Arcomed A.G. Medical Systems
Consort Medical plc
JMS CO., LTD.
NIPRO CORPORATION
Edwards Lifesciences Corporation
Teleflex Incorporated
Cook Medical Incorporated
INJEX - Equidyne Systems
Bioject Medical Technologies Inc.
Table of Contents
1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 Drug Delivery Devices in Middle East and Africa
3.1 Drug Delivery Devices Cross Country Comparison, Revenue ($m), 2003-2017
3.2 Drug Delivery Devices, Middle East and Africa, Overall Revenue ($m), 2003-2017
3.3 Drug Delivery Devices, Middle East and Africa, Category Volume (Units), 2003-2017
3.4 Drug Delivery Devices, Middle East and Africa, Company share (2009-2010)
4 Drug Delivery Devices In South Africa
4.1 Drug Delivery Devices, South Africa, Overall Revenue ($m), 2003-2017
4.2 Drug Delivery Devices, South Africa, Category Volume (Units), 2003-2017
4.3 Drug Delivery Devices, South Africa, Distribution Share (2009-2010)
4.3.1 Central Venous Catheters, South Africa, Distribution Share (2009-2010)
4.3.2 Infusion Systems, South Africa, Distribution Share (2009-2010)
4.3.3 Metered Dose Inhaler Devices, South Africa, Distribution Share (2009-2010)
4.3.4 Needle Free Injections, South Africa, Distribution Share (2009-2010)
4.4 Drug Delivery Devices, South Africa, Company Share (2009-2010)
4.4.1 Drug Delivery Devices, South Africa, Company Share (2009-2010)
4.4.2 Central Venous Catheters, South Africa, Company Share (2009-2010)
4.4.3 Infusion Systems, South Africa, Company Share (2009-2010)
4.4.4 Metered Dose Inhaler Devices, South Africa, Company Share (2009-2010)
4.4.5 Needle Free Injections, South Africa, Company Share (2009-2010)
5 Drug Delivery Devices In Israel
5.1 Drug Delivery Devices, Israel, Overall Revenue ($m), 2003-2017
5.2 Drug Delivery Devices, Israel, Category Volume (Units), 2003-2017
5.3 Drug Delivery Devices, Israel, Distribution Share (2009-2010)
5.3.1 Central Venous Catheters, Israel, Distribution Share (2009-2010
5.3.2 Infusion Systems, Israel, Distribution Share (2009-2010
5.3.3 Metered Dose Inhaler Devices, Israel, Distribution Share (2009-2010
5.3.4 Needle Free Injections, Israel, Distribution Share (2009-2010)
5.4 Drug Delivery Devices, Israel, Company Share (2009-2010)
5.4.1 Drug Delivery Devices, Israel, Company Share (2009-2010)
5.4.2 Central Venous Catheters, Israel, Company Share (2009-2010)
5.4.3 Infusion Systems, Israel, Company Share (2009-2010)
5.4.4 Metered Dose Inhaler Devices, Israel, Company Share (2009-2010)
5.4.5 Needle Free Injections, Israel, Company Share (2009-2010)
6 Drug Delivery Devices In Saudi Arabia
6.1 Drug Delivery Devices, Saudi Arabia, Overall Revenue ($m), 2003-2017
6.2 Drug Delivery Devices, Saudi Arabia, Category Volume (Units), 2003-2017
6.3 Drug Delivery Devices, Saudi Arabia, Distribution Share (2009-2010)
6.3.1 Central Venous Catheters, Saudi Arabia, Distribution Share (2009-2010)
6.3.2 Infusion Systems, Saudi Arabia, Distribution Share (2009-2010)
6.3.3 Metered Dose Inhaler Devices, Saudi Arabia, Distribution Share (2009-2010)
6.3.4 Needle Free Injections, Saudi Arabia, Distribution Share (2009-2010)
6.4 Drug Delivery Devices, Saudi Arabia, Company Share (2009-2010)
6.4.1 Drug Delivery Devices, Saudi Arabia, Company Share (2009-2010)
6.4.2 Central Venous Catheters, Saudi Arabia, Company Share (2009-2010)
6.4.3 Infusion Systems, Saudi Arabia, Company Share (2009-2010)
6.4.4 Metered Dose Inhaler Devices, Saudi Arabia, Company Share (2009-2010)
6.4.5 Needle Free Injections, Saudi Arabia, Company Share (2009-2010)
7 Overview of Key Companies in Middle East and Africa Drug Delivery Devices Market
7.1 GlaxoSmithKline plc
7.1.1 Company Overview
7.1.2 Share in the Middle East and Africa Drug Delivery Devices Market
7.2 AstraZeneca International plc
7.2.1 Company Overview
7.2.2 Share in the Middle East and Africa Drug Delivery Devices Market
7.3 Boehringer Ingelheim GmbH
7.3.1 Company Overview
7.3.2 Share in the Middle East and Africa Drug Delivery Devices Market
7.4 Cipla Medpro (Pty) Ltd.
7.4.1 Company Overview
7.4.2 Share in the Middle East and Africa Drug Delivery Devices Market
7.5 Hospira, Inc.
7.5.1 Company Overview
7.5.2 Share in the Middle East and Africa Drug Delivery Devices Market
7.6 B. Braun Melsungen AG
7.6.1 Company Overview
7.6.2 Share in the Middle East and Africa Drug Delivery Devices Market
7.7 Fresenius Kabi AG
7.7.1 Company Overview
7.8 Medtronic, Inc.
7.8.1 Company Overview
7.9 Baxter International Inc.
7.9.1 Company Overview
7.10 Smiths Medical
7.10.1 Company Overview
7.11 Terumo Corporation
7.11.1 Company Overview
7.12 CareFusion Corporation
7.12.1 Company Overview
7.13 3M Health Care
7.13.1 Company Overview
7.14 Arcomed A.G. Medical Systems
7.14.1 Company Overview
7.15 Consort Medical plc
7.15.1 Company Overview
7.16 JMS CO., LTD.
7.16.1 Company Overview
7.17 NIPRO CORPORATION
7.17.1 Company Overview
7.18 Edwards Lifesciences Corporation
7.18.1 Company Overview
7.19 Teleflex Incorporated
7.19.1 Company Overview
7.20 Cook Medical Incorporated
7.20.1 Company Overview
7.21 INJEX - Equidyne Systems
7.21.1 Company Overview
7.22 Bioject Medical Technologies Inc.
7.22.1 Company Overview
8 Drug Delivery Devices Market Pipeline Products
9 Appendix
9.1 Definitions of Markets Covered in the Report
9.1.1 Drug Delivery Devices
9.2 Research Methodology
9.3 Secondary Research
9.4 Primary Research
9.5 Models
9.6 Forecasts
9.7 Expert Panels
9.8 GlobalData Consulting
9.9 Currency Conversion
9.10 Contact Us
9.11 Disclaimer
List of Tables
1.1 List of Tables
Table 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m), 2003-2017
Table 2: Drug Delivery Devices, Middle East and Africa, Overall Revenue ($m), 2003-2017
Table 3: Drug Delivery Devices, Middle East and Africa, Cross-Category Analysis, 2003-2017
Table 4: Drug Delivery Devices, Middle East and Africa, Overall Revenue ($m), Historic, 2003-2010
Table 5: Drug Delivery Devices, Middle East and Africa, Overall Revenue ($m), Forecast, 2010-2017
Table 6: Drug Delivery Devices, Middle East and Africa, Category Volume (Units), 2003-2017
Table 7: Drug Delivery Devices, Middle East and Africa, Category Volume (Units), Historic, 2003-2010
Table 8: Drug Delivery Devices, Middle East and Africa, Category Volume (Units), Forecast, 2010-2017
Table 9: Drug Delivery Devices, Middle East and Africa, Company share by Revenue ($m), 2009-2010
Table 10: Drug Delivery Devices, South Africa, Overall Revenue ($m), 2003-2017
Table 11: Drug Delivery Devices, South Africa, Overall Revenue ($m), Historic, 2003-2010
Table 12: Drug Delivery Devices, South Africa, Overall Revenue ($m), Forecast, 2010-2017
Table 13: Drug Delivery Devices, South Africa, Category Volume (Units), 2003-2017
Table 14: Drug Delivery Devices, South Africa, Category Volume (Units), Historic, 2003-2010
Table 15: Drug Delivery Devices, South Africa, Category Volume (Units), Forecast, 2010-2017
Table 16: Central Venous Catheters, South Africa, Distribution Share by Revenue ($m), 2009-2010
Table 17: Infusion Systems, South Africa, Distribution Share by Revenue ($m), 2009-2010
Table 18: Metered Dose Inhaler Devices, South Africa, Distribution Share by Revenue ($m), 2009-2010
Table 19: Needle Free Injections, South Africa, Distribution Share by Revenue ($m), 2009-2010
Table 20: Drug Delivery Devices, South Africa, Company Share by Revenue ($m), 2009-2010
Table 21: Central Venous Catheters, South Africa, Company Share by Revenue ($m), 2009-2010
Table 22: Infusion Systems, South Africa, Company Share by Revenue ($m), 2009-2010
Table 23: Metered Dose Inhaler Devices, South Africa, Company Share by Revenue ($m), 2009-2010
Table 24: Needle Free Injections, South Africa, Company Share by Revenue ($m), 2009-2010
Table 25: Drug Delivery Devices, Israel, Overall Revenue ($m), 2003-2017
Table 26: Drug Delivery Devices, Israel, Overall Revenue ($m), Historic, 2003-2010
Table 27: Drug Delivery Devices, Israel, Overall Revenue ($m), Forecast, 2010-2017
Table 28: Drug Delivery Devices, Israel, Category Volume (Units), 2003-2017
Table 29: Drug Delivery Devices, Israel, Category Volume (Units), Historic, 2003-2010
Table 30: Drug Delivery Devices, Israel, Category Volume (Units), Forecast, 2010-2017
Table 31: Central Venous Catheters, Israel, Distribution Share by Revenue ($m), 2009-2010
Table 32: Infusion Systems, Israel, Distribution Share by Revenue ($m), 2009-2010
Table 33: Metered Dose Inhaler Devices, Israel, Distribution Share by Revenue ($m), 2009-2010
Table 34: Needle Free Injections, Israel, Distribution Share by Revenue ($m), 2009-2010
Table 35: Drug Delivery Devices, Israel, Company Share by Revenue ($m), 2009-2010
Table 36: Central Venous Catheters, Israel, Company Share by Revenue ($m), 2009-2010
Table 37: Infusion Systems, Israel, Company Share by Revenue ($m), 2009-2010
Table 38: Metered Dose Inhaler Devices, Israel, Company Share by Revenue ($m), 2009-2010
Table 39: Needle Free Injections, Israel, Company Share by Revenue ($m), 2009-2010
Table 40: Drug Delivery Devices, Saudi Arabia, Overall Revenue ($m), 2003-2017
Table 41: Drug Delivery Devices, Saudi Arabia, Overall Revenue ($m), Historic, 2003-2010
Table 42: Drug Delivery Devices, Saudi Arabia, Overall Revenue ($m), Forecast, 2010-2017
Table 43: Drug Delivery Devices, Saudi Arabia, Category Volume (Units), 2003-2017
Table 44: Drug Delivery Devices, Saudi Arabia, Category Volume (Units), Historic, 2003-2010
Table 45: Drug Delivery Devices, Saudi Arabia, Category Volume (Units), Forecast, 2010-2017
Table 46: Central Venous Catheters, Saudi Arabia, Distribution Share by Revenue ($m), 2009-2010
Table 47: Infusion Systems, Saudi Arabia, Distribution Share by Revenue ($m), 2009-2010
Table 48: Metered Dose Inhaler Devices, Saudi Arabia, Distribution Share by Revenue ($m), 2009-2010
Table 49: Needle Free Injections, Saudi Arabia, Distribution Share by Revenue ($m), 2009-2010
Table 50: Drug Delivery Devices, Saudi Arabia, Company Share by Revenue ($m), 2009-2010
Table 51: Central Venous Catheters, Saudi Arabia, Company Share by Revenue ($m), 2009-2010
Table 52: Infusion Systems, Saudi Arabia, Company Share by Revenue ($m), 2009-2010
Table 53: Metered Dose Inhaler Devices, Saudi Arabia, Company Share by Revenue ($m), 2009-2010
Table 54: Needle Free Injections, Saudi Arabia, Company Share by Revenue ($m), 2009-2010
Table 55: Drug Delivery Devices Market Pipeline Products
Table 56: USD to Local Currency, Middle East and Africa, Average Exchange Rate 2003-20010
List of Figures
1.2 List of Figures
Figure 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m), 2003-2017
Figure 2: Drug Delivery Devices, Middle East and Africa, Overall Revenue ($m), 2003-2017
Figure 3: Drug Delivery Devices, Middle East and Africa, Cross-Category Analysis, 2003-2017
Figure 4: Drug Delivery Devices, Middle East and Africa, Overall Revenue ($m), Historic, 2003-2010
Figure 5: Drug Delivery Devices, Middle East and Africa, Overall Revenue ($m), Forecast, 2010-2017
Figure 6: Drug Delivery Devices, Middle East and Africa, Category Volume (Units), 2003-2017
Figure 7: Drug Delivery Devices, Middle East and Africa, Category Volume (Units), Historic, 2003-2010
Figure 8: Drug Delivery Devices, Middle East and Africa, Category Volume (Units), Forecast, 2010-2017
Figure 9: Drug Delivery Devices, Middle East and Africa, Company share (%), 2010
Figure 10: Drug Delivery Devices, South Africa, Overall Revenue ($m), 2003-2017
Figure 11: Drug Delivery Devices, South Africa, Overall Revenue ($m), Historic, 2003-2010
Figure 12: Drug Delivery Devices, South Africa, Overall Revenue ($m), Forecast, 2010-2017
Figure 13: Drug Delivery Devices, South Africa, Category Volume (Units), 2003-2017
Figure 14: Drug Delivery Devices, South Africa, Category Volume (Units), Historic, 2003-2010
Figure 15: Drug Delivery Devices, South Africa, Category Volume (Units), Forecast, 2010-2017
Figure 16: Drug Delivery Devices, South Africa, Company Share (%), 2010
Figure 17: Central Venous Catheters, South Africa, Company Share (%), 2010
Figure 18: Infusion Systems, South Africa, Company Share (%), 2010
Figure 19: Metered Dose Inhaler Devices, South Africa, Company Share (%), 2010
Figure 20: Needle Free Injections, South Africa, Company Share (%), 2010
Figure 21: Drug Delivery Devices, Israel, Overall Revenue ($m), 2003-2017
Figure 22: Drug Delivery Devices, Israel, Overall Revenue ($m), Historic, 2003-2010
Figure 23: Drug Delivery Devices, Israel, Overall Revenue ($m), Forecast, 2010-2017
Figure 24: Drug Delivery Devices, Israel, Category Volume (Units), 2003-2017
Figure 25: Drug Delivery Devices, Israel, Category Volume (Units), Historic, 2003-2010
Figure 26: Drug Delivery Devices, Israel, Category Volume (Units), Forecast, 2010-2017
Figure 27: Drug Delivery Devices, Israel, Company Share (%), 2010
Figure 28: Central Venous Catheters, Israel, Company Share (%), 2010
Figure 29: Infusion Systems, Israel, Company Share (%), 2010
Figure 30: Metered Dose Inhaler Devices, Israel, Company Share (%), 2010
Figure 31: Needle Free Injections, Israel, Company Share (%), 2010
Figure 32: Drug Delivery Devices, Saudi Arabia, Overall Revenue ($m), 2003-2017
Figure 33: Drug Delivery Devices, Saudi Arabia, Overall Revenue ($m), Historic, 2003-2010
Figure 34: Drug Delivery Devices, Saudi Arabia, Overall Revenue ($m), Forecast, 2010-2017
Figure 35: Drug Delivery Devices, Saudi Arabia, Category Volume (Units), 2003-2017
Figure 36: Drug Delivery Devices, Saudi Arabia, Category Volume (Units), Historic, 2003-2010
Figure 37: Drug Delivery Devices, Saudi Arabia, Category Volume (Units), Forecast, 2010-2017
Figure 38: Drug Delivery Devices, Saudi Arabia, Company Share (%), 2010
Figure 39: Central Venous Catheters, Saudi Arabia, Company Share (%), 2010
Figure 40: Infusion Systems, Saudi Arabia, Company Share (%), 2010
Figure 41: Metered Dose Inhaler Devices, Saudi Arabia, Company Share (%), 2010
Figure 42: Needle Free Injections, Saudi Arabia, Company Share (%), 2010
Figure 43: GlaxoSmithKline plc, Company Share (%), Middle East and Africa Drug Delivery Devices Market, 2010
Figure 44: AstraZeneca PLC, Company Share (%), Middle East and Africa Drug Delivery Devices Market, 2010
Figure 45: Boehringer Ingelheim GmbH, Company Share (%), Middle East and Africa Drug Delivery Devices Market, 2010
Figure 46: Cipla Medpro (Pty) Ltd., Company Share (%), Middle East and Africa Drug Delivery Devices Market, 2010
Figure 47: Hospira, Inc., Company Share (%), Middle East and Africa Drug Delivery Devices Market, 2010
Figure 48: B. Braun Melsungen AG, Company Share (%), Middle East and Africa Drug Delivery Devices Market, 2010
